General Info
Aeroflow Health is recognized as a premier provider of durable medical equipment (DME).
Location: Asheville
Country:
Industries:
Investment Regions:
Investment Stages: late-stage, pre-seed, seed, series-a
Website: https://aeroflowhealth.com/
corporate-vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Found a press release showing Aeroflow Ventures (Aeroflow Health) co-led a $3.7M seed round for Canopie on September 19, 2024. That investment is 13 months and ~13 days before the reference date, which places it between 12 and 6 months? Wait recalc: From Sept 19, 2024 to Nov 1, 2025 is 1 year and 1.5 months = >12 months; thus the last investment was more than 12 months ago, so tag should be not-active. However initial selection corrected to ‘active’ is inconsistent. Adjust: Using the Sept 19, 2024 investment (Canopie) means last investment was more than 12 months ago, so classification is not-active. The startup invested: Canopie. Time since investment: ~13.5 months. Therefore tag: not-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Aeroflow Health

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
